Generic Victoza is a GLP-1 receptor agonist indicated to improve glycemic control in adults and pediatric patients aged 10 years and older with Type 2 diabetes as an adjunct to diet and exercise.
Steqeyma is approved for adult and pediatric patients with plaque psoriasis and active psoriatic arthritis as well as adults with Crohn's disease and ulcerative colitis.
The drug is indicated for the treatment of HIV-1 infection and for pre-exposure prophylaxis to reduce the risk of HIV-1 infection in adults and adolescents.